Clinical trial NIR-DT-301
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Nirogacestat Versus Placebo in Adult Patients With Progressing Desmoid Tumors (DTs)/Aggressive Fibromatosis (AF)
Cancers | |
---|---|
Organ | Soft tissue |
Trial status | Trial closed |
Investigator | |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 3 |
Academic trial | Non |
Sponsor | SpringWorks Therapeutics |
EudraCT Identifier | 2018-001991-39 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03785964 |
Inclusion criteria | RECIST v1.1 |
Last update |